THY1 and cancer: To gain a better understanding of the potential for MSCs in cancer immunotherapy, in this study, we profiled the phenotypes of mouse compact bone derived MSCs (CB-MSCs) and found that CB-MSCs are different from bone marrow derived MSCs (BM-MSCs) in CD90 expression.